Dextran-functionalized magnetic fluid mediating magnetohyperthermia combined with preventive antioxidant pequi-oil supplementation: Potential use against cancer

Journal of Biomedical Nanotechnology

Volumn 9, Issue 7, 2013, Pages 1261-1271

  Miranda Vilela, Ana Luisa ^a   Peixoto, Raphael Cândido Apolinário ^a   Longo, João Paulo Figueiró ^a   E Cintra, Débora De Oliveira Silva ^a   Portilho, Flávia Arruda ^a   Miranda, Kely Lopes Caiado ^b   Sartoratto, Patrícia Pommé Confessori ^b   Báo, Sônia Nair ^a   De Azevedo, Ricardo Bentes ^a   Lacava, Zulmira Guerrero Marques ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Dextran coated maghemite nanoparticles; Magnetic nanoparticles; Magnetohyperthermia; Nanobiotechnology; Pequi oil (Caryocar brasiliense Camb)

Indexed keywords

ALTERNATING CURRENT; CANCER THERAPY; INTRATUMORAL INJECTION; MAGHEMITE NANOPARTICLE; MAGNETIC NANO-PARTICLES; MAGNETOHYPERTHERMIA; PEQUI OIL (CARYOCAR BRASILIENSE CAMB); TUMOR NECROSIS;

ANTIOXIDANTS; DEXTRAN; DISEASES; MAGNETIC FLUIDS; NANOBIOTECHNOLOGY; NANOPARTICLES;

TUMORS;

ANTIOXIDANT; DEXTRAN; DEXTRAN FUNCTIONALIZED MAGNETIC FLUID; MAGNETIC NANOPARTICLE; PEQUI OIL; UNCLASSIFIED DRUG;

ALTERNATING CURRENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CHEMICAL COMPOSITION; COMET ASSAY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; EHRLICH ASCITES TUMOR; FEMALE; HEMATOLOGY; HISTOPATHOLOGY; HYPERTHERMIA; LYMPHOCYTE; MAGNETIC FIELD; MAGNETOHYPERTHERMIA; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR NECROSIS;

ANIMALS; ANTIOXIDANTS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DEXTRANS; FEASIBILITY STUDIES; HYPERTHERMIA, INDUCED; MAGNETIC FIELD THERAPY; PLANT OILS; TREATMENT OUTCOME;

EID: 84880549805     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1616     Document Type: Article

References (56)

1. H. S. Santos and W. M. S. Cruz, A terapia nutricional com vitaminas antioxidantes e o tratamento quimioterápico oncológico. Rev. Bras. Cancerol. 47, 303 (2001).
2. C. Borek, Dietary antioxidants and human cancer. Integr. Cancer Ther. 3, 333 (2004).
3. T. Ozben, Oxidative stress and apoptosis: Impact on cancer therapy. J. Pharm. Sci. 96, 2181 (2007).
4. P. Tartaj, M. D. P. Morales, S. Veintemillas-Verdaguer, T. González-Carreño, and C. J. Serna, The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys. 36, R182 (2003).
5. L. S. Barbosa, N. Sadeghiani, M. H. A. Guedes, D. M. Oliveira, A. C. Tedesco, E. C. O. Lima, R. B. Azevedo, P. C. Morais, and Z. G. M. Lacava, Effects of magnetic field and magnetoliposomes on mice: Cytotoxicity and genotoxicity tests. IEEE Trans. Magn. 42, 3605 (2006).
6. C. C. Berry and A. S. G. Curtis, Fictionalization of magnetic nanoparticles for applications in biomedicine: Topical review. J. Phys. D: Appl. Phys. 36, R198 (2003).
7. F. A. Portilho, L. L. C. Estevanato, A. L. Miranda-Vilela, M. F. M. Almeida-Santos, B. M. Lacava, A. Simioni, A. C. Tedesco, P. C. Morais, and Z. G. M. Lacava, Investigation of a magnetohyperthermia system efficacy. J. Appl. Phys. 109, 07B307 (2011).
8. Y. Zhai, H. Xie, and H. Gu, Effects of hyperthermia with dextran magnetic fluid on the growth of grafted H22 tumor in mice. Int. J. Hyperth. 25, 65 (2009).
9. M. H. A. Guedes, M. E. A. Guedes, P. C. Morais, M. F. da Silva, T. S. Santos, J. P. Alves, Jr, C. E. Bertelli, R. B. Azevedo, and Z. G. M. Lacava, Proposal of a magnetohyperthermia system: Preliminary biological tests. J. Magn. Magn. Mat. 272-276, 2406 (2004).
10. M. H. A. Guedes, N. Sadeghiani, D. L. G. Peixoto, J. P. Coelho, L. S. Barbosa, R. B. Azevedo, S. Kückelhaus, M. F. da Silva, P. C. Morais, and Z. G. M. Lacava, Effects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice peritoneal cells. J. Magn. Magn. Mat. 293, 283 (2005).
11. J. Riemer, H. H. Hoepken, H. Czerwinska, S. R. Robinson, and R. Dringen, Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 331, 370 (2004).
12. M. Hermes-Lima, Functional Metabolism: Regulation and Adaptation, edited by K. B. Storey, Hoboken, New Jersey (2004), Chap. 12, pp. 319-368.
13. B. N. Ames, M. K. Shigenaga, and I. M. Hagen, Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. 90, 7915 (1993).
14. C. H. Azevedo-Meleiro and D. B. Rodriguez-Amaya, Confirmation of the identity of the carotenoids of tropical fruits by HPLC-DAD and HPLC-MS. J. Food Compos. Anal. 17, 385 (2004).
15. A. Lima, A. M. O. Silva, R. A. Trindade, R. P. Torres, and J. Mancini-Filho, Composição química e compostos bioativos presentes na polpa e na amêndoa do pequi (Caryocar brasiliense Camb.). Rev. Bras. Frutic. 29, 695 (2007).
16. M. N. S. Oliveira, E. Gusmão, P. S. N. Lopes, M. O. M. Simões, L. M. D. Ribeiro, and B. A. Souto, Estádio de maturação dos frutos e fatores relacionados aos aspectos nutritivos e de textura da polpa de pequi (Caryocar brasiliense Camb.). Rev. Bras. Frutic. 28, 380-386 (2006).
17. L. M. Cardoso, B. L. Reis, F. R. Hamacek, and H. M. P. Sant'Ana, Chemical characteristics and bioactive compounds of cooked Pequi fruits (Caryocar brasiliense Camb.) from the brazilian cerrado. Fruits 68, 3 (2013).
18. H. S. Akbas, M. Timur, and T. Ozben, Concurrent use of antioxidants in cancer therapy: An update. Expert. Rev. Clin. Immunol. 2, 931 (2006).
19. A. L. Miranda-Vilela, F. A. Portilho, V. G. de Araujo, L. L. C. Estevanato, B. P. Mezzomo, M. D. de Almeida-Santos, and Z. G. M. Lacava, The protective effects of nutritional antioxidant therapy on Ehrlich solid tumor-bearing mice depend on the type of antioxidant therapy chosen: Histology, genotoxicity and hematology evaluations. J. Nutr. Biochem. 22, 1091 (2011).
20. B. S. Ferreira, C. G. Almeida, L. P. Faza, A. Almeida, C. G. Diniz, V. L. Silva, R. M. Grazul, and M. L. Hyaric, Comparative properties of amazonian oils obtained by different extraction methods. Molecules 16, 5875 (2011).
21. A. L. Miranda-Vilela, I. S. Resck, and C. K. Grisolia, Antigenotoxic activity and antioxidant properties of organic and aqueous extracts of pequi fruit (Caryocar brasiliense Camb.) pulp. Genet. Mol. Biol. 31, 956 (2008).
22. A. L. Miranda-Vilela, A. K. Akimoto, P. C. Z. Alves, L. C. S. Pereira, C. A. Gonçalves, M. N. Klautau-Guimarães, and C. K. Grisolia, Dietary carotenoid-rich pequi oil reduces plasma lipid peroxidation and DNA damage in runners and evidence for an association with MnSOD genetic variant-Val9Ala. Genet. Mol. Res. 8, 1481 (2009).
23. A. L. Miranda-Vilela, A. K. Akimoto, P. C. Z. Alves, L. C. S. Pereira, M. N. Klautau-Guimarães, and C. K. Grisolia, Dietary carotenoid-rich oil supplementation improves exerciseinduced anisocytosis in runners: Influences of haptoglobin, MnSOD (Val9Ala), CAT (21A/T) and GPX1 (Pro198Leu) gene polymorphisms in dilutional pseudoanemia ("sports anemia"). Genet. Mol. Biol. 33, 359 (2010).
24. A. L. Miranda-Vilela, P. C. Z. Alves, A. K. Akimoto, G. S. Lordelo, M. N. Klautau-Guimarães, and C. K. Grisolia, Under increased hydrogen peroxide conditions, the antioxidant effects of pequi oil (Caryocar brasiliense camb.) to decrease DNA damage in runners are influenced by sex, age and oxidative stress-related genetic polymorphisms. Free Rad. Antiox. 1, 27 (2011).
25. A. L. Miranda-Vilela, L. C. S. Pereira, C. A. Gonçalves, and C. K. Grisolia, Pequi fruit (Caryocar brasiliense Camb.) pulp oil reduces exercise-induced inflammatory markers and blood pressure of male and female runners. Nutr. Res. 29, 850 (2009).
26. Y. Sun, L. W. Oberley, H. Elwel, and E. Sierra-Rivera, Antioxidant enzyme activities in normal and transformed mouse liver cells. Int. J. Cancer 44, 1028 (1989).
27. Y. Sun, N. H. Colburn, and L. W. Oberley, Depression of catalase gene expression after immortalization and transformation of mouse liver cells. Carcinogenesis 14, 1505 (1993).
28. K. Punnonen, M. Ahotupa, K. Asaishi, M. Hyöty, R. Kudo, and R. Punnonen, Antioxidant enzyme activities and oxidative stress in human breast cancer. J. Cancer Res. Clin. Oncol. 120, 374 (1994).
29. C. Abiaka, F. Al-Awadi, H. Al-Sayer, S. Gulshan, B. Behbehani, and M. Farghally, Activities of erythrocyte antioxidant enzymes in cancer patients. J. Clin. Lab. Anal. 16, 167 (2002).
30. H. Dursun, M. Bilici, A. Uyanik, N. Okcu, and M. Akyüz, Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer. J. Int. Med. Res. 34, 193 (2006).
31. L. M. Lacava, Z. G. M. Lacava, M. F. da Silva, O. Silva, S. B. Chaves, R. B. Azevedo, F. Pelegrini, C. Gansau, N. Buske, D. Sabolovic, and P. C. Morais, Magnetic resonance of a dextrancoated magnetic fluid intravenously administered in mice. Biophys. J. 80, 2483 (2001).
32. L. M. Lacava, Z. G. M. Lacava, R. B. Azevedo, S. B. Chaves, V. A. P. Garcia, O. Silva, F. Pelegrini, N. Buske, C. Gansau, M. F. da Silva, and P. C. Morais, Use of magnetic resonance to study biodistribution of dextran-coated magnetic fluid intravenously administered in mice. J. Magn. Magn. Mater. 252, 367 (2002).
33. L. M. Lacava, V. A. P. Garcia, S. Kückelhaus, R. B. Azevedo, Z. G. M. Lacava, O. Silva, F. Pelegrini, C. Gansau, N. Buske, and P. C. Morais, Magnetic resonance and light microscopy investigation of a dextran coated magnetic fluid. J. Appl. Phys. 93, 7563 (2003).
34. L. M. Lacava, V. A. P. Garcia, S. Kückelhaus, R. B. Azevedo, N. Sadeghiani, N. Buske, P. C. Morais, and Z. G. M. Lacava, Longterm retention of dextran-coated magnetite nanoparticles in the liver and spleen, J. Magn. Magn. Mater. 272-276, 2434 (2004).
35. L. L. C. Estevanato, L. M. Lacava, L. C. F. Carvalho, O. Silva, F. Pelegrini, S. N. Bao, P. C. Morais, and Z. G. M. Lacava, Long-term biodistribution and biocompatibility investigation of dextran-coated magnetite nanoparticle using mice as the animal model. J. Biomed. Nanotechnol. 8, 301 (2012).
36. T. J. Key, P. K. Verkasalo, and E. Banks, Epidemiology of breast cancer. Lancet Oncol. 2, 133 (2001).
37. A. L. Miranda-Vilela, I. S. Resck, M. A. Mendonça, and C. K. Grisolia, Characterization of the major nutritional components of caryocar brasiliense fruit pulp by NMR spectroscopy. Quim. Nova 32, 2310 (2009).
38. S. Reagan-Shaw, M. Nihal, and N. Ahmad, Dose translation from animal to human studies revisited. FASEB J. 22, 659 (2007).
39. M. Yanase, M. Shinkai, H. Honda, T. Wakabayashi, J. Yoshida, and T. Kobayashi, Intracellular hyperthermia for cancer using magnetite cationic liposomes:Anin vivo study. Jpn. J. Cancer Res. 89, 463 (1998).
40. K. Maier-Hauff, F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Thiesen, H. Orawa, V. Budach, and A. Jordan, Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103, 317 (2011).
41. B. Thiesen and A. Jordan, Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia. 24, 467 (2008).
42. C. Leuschner, C. S. Kumar, W. Hansel, W. Soboyejo, J. Zhou, and J. Hormes, LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res. Treat. 99, 163 (2006).
43. J. Zhou, C. Leuschner, C. Kumar, J. Hormes, and W. O. Soboyejo, A TEM study of functionalized magnetic nanoparticles targeting breast cancer cells. Mater. Sci. Eng. C 26, 1451 (2006).
44. J. Zhou, C. Leuschner, C. Kumar, J. F. Hormes, and W. O. Soboyejo, Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 27, 2001 (2006).
45. R. T. Branca, Z. I. Cleveland, B. Fubara, C. S. S. R. Kumar, R. R. Maronpot, C. Leuschner, W. S. Warren, and B. Driehuys, Molecular MRI for sensitive and specific detection of lung metastases. Proc. Natl. Acad. Sci. USA 107, 3693 (2010).
46. A. Rastogi, Nanooncology: The breast cancer story. Univ. Tor. Med. J. 88, 190 (2011).
47. R. C. Plaza, J. L. Arias, M. Espín, M. L. Jiménez, and A. V. Delgado, Aging effects in the electrokinetics of colloidal iron oxides. J. Colloid Interface Sci. 245, 86 (2002).
48. L. L. C. Estevanato, J. R. da Silva, A. M. Falqueiro, E. Mosiniewicz-Szablewska, P. Suchocki, A. C. Tedesco, P. C. Morais, and Z. G. M. Lacava, Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: In vitro valuation of cytotoxicity and magnetohyperthermia efficacy. Int. J. Nanomed. 7, 5287 (2012).
49. M. C. da Paz, M. F. M. Almeida-Santos, C. M. B. Santos, S. W. da Silva, L. B. de Souza, E. C. D. Lima, R. C. Silva, C. M. Lucci, P. C. Morais, R. B. Azevedo, and Z. G. M. Lacava, Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer. Int. J. Nanomed. 7, 5271 (2012).
50. G. Sarfati, T. Dvir, M. Elkabets, R. N. Apte, and S. Cohen, Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Biomaterials 32, 152 (2011).
51. G. A. Hughes, Nanostructure-mediated drug delivery. Nanomedicine 1, 22 (2005).
52. J. L. Data and A. S. Nies, Drugs five years later: Dextran. Ann. Intern. Med. 81, 500 (1974).
53. M. A. Zago, R. P. Falcão, and R. Pasquini, Hematologia: Fundamentos e Prática, Athene, São Paulo (2004).
54. E. Everds, The mouse in Biomedical Research - Normative Biology, Husbandry, and Models, edited by J. G. Fox, S. W. Barthold, M. T. Davison, C. E. Newcomer, F. W. Quimby, and A. L. Smith, Academic Press, California (2006), Vol. 3, pp. 133-170.
55. G. Manda, M. T. Nechifor, and T. M. Neagu, Reactive oxygen species, cancer and anti-cancer therapies. Curr. Chem. Biol. 3, 342 (2009).
56. M. A. Thrall, Hematologia e Bioquímica Clínica Veterinária, Roca, São Paulo (2007). Development